HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer.
Saved in:
| Title: | HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer. |
|---|---|
| Authors: | Lin, Ting-I1,2 (AUTHOR), Tseng, Yi-Ru1,2 (AUTHOR), Dong, Min-Jyun1,2 (AUTHOR), Lin, Chih-Yi1,2 (AUTHOR), Chung, Wei-Ting1,2 (AUTHOR), Liu, Chun-Yu1,3,4,5 (AUTHOR), Tsai, Yi-Fang3,4,6 (AUTHOR), Huang, Chi-Cheng3,4,6 (AUTHOR), Tseng, Ling-Ming3,4,6 (AUTHOR), Chao, Ta-Chung1,3,4,5 (AUTHOR), Lai, Jiun-I1,2,3,4,5 (AUTHOR) jilai@nycu.edu.tw |
| Source: | Clinical Epigenetics. 2/26/2025, Vol. 17 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 183284056 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lin%2C+Ting-I%22">Lin, Ting-I</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tseng%2C+Yi-Ru%22">Tseng, Yi-Ru</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dong%2C+Min-Jyun%22">Dong, Min-Jyun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Chih-Yi%22">Lin, Chih-Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chung%2C+Wei-Ting%22">Chung, Wei-Ting</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Chun-Yu%22">Liu, Chun-Yu</searchLink><relatesTo>1,3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsai%2C+Yi-Fang%22">Tsai, Yi-Fang</searchLink><relatesTo>3,4,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Chi-Cheng%22">Huang, Chi-Cheng</searchLink><relatesTo>3,4,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tseng%2C+Ling-Ming%22">Tseng, Ling-Ming</searchLink><relatesTo>3,4,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chao%2C+Ta-Chung%22">Chao, Ta-Chung</searchLink><relatesTo>1,3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lai%2C+Jiun-I%22">Lai, Jiun-I</searchLink><relatesTo>1,2,3,4,5</relatesTo> (AUTHOR)<i> jilai@nycu.edu.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+Epigenetics%22">Clinical Epigenetics</searchLink>. 2/26/2025, Vol. 17 Issue 1, p1-14. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=183284056 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13148-025-01834-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Titles: – TitleFull: HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin, Ting-I – PersonEntity: Name: NameFull: Tseng, Yi-Ru – PersonEntity: Name: NameFull: Dong, Min-Jyun – PersonEntity: Name: NameFull: Lin, Chih-Yi – PersonEntity: Name: NameFull: Chung, Wei-Ting – PersonEntity: Name: NameFull: Liu, Chun-Yu – PersonEntity: Name: NameFull: Tsai, Yi-Fang – PersonEntity: Name: NameFull: Huang, Chi-Cheng – PersonEntity: Name: NameFull: Tseng, Ling-Ming – PersonEntity: Name: NameFull: Chao, Ta-Chung – PersonEntity: Name: NameFull: Lai, Jiun-I IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 02 Text: 2/26/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 18687075 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Clinical Epigenetics Type: main |
| ResultId | 1 |